5-Allyloxy-AMT, also known as 5-allyloxy-α-methyltryptamine, is a serotonin 5-HT2 receptor agonist of the tryptamine, 5-alkyloxytryptamine, and α-alkyltryptamine families.[1]
![]() | |
Clinical data | |
---|---|
Other names | 5-Allyloxy-αMT; 5-AlO-AMT; 5-AlO-αMT; 5-Allyloxy-α-methyltryptamine; 2-(5-Allyloxy-1H-indol-3-yl)-1-methylethylamine; Compound 122 |
Drug class | Serotonin 5-HT2 receptor agonist |
Identifiers | |
| |
Chemical and physical data | |
Formula | C14H18N2O |
Molar mass | 230.311 g·mol−1 |
3D model (JSmol) | |
| |
|
It is known to act as high-efficacy partial agonist or near-full agonist of the serotonin 5-HT2A receptor (EC50 = 162 nM; Emax = 89%) and of the serotonin 5-HT2B receptor (EC50 = 60 nM; Emax = 82%), whereas activity at the serotonin 5-HT2C receptor and other serotonin receptors was not reported.[1]
5-Allyloxy-AMT was the most potent serotonin 5-HT2A receptor agonist reported in a large series of tryptamines that was evaluated in search of potent and selective serotonin 5-HT2B receptor agonists.[1] The only exceptions were the reference serotonin 5-HT2A receptor agonists serotonin (5-HO-T) (EC50 = 79 nM; Emax = 100%) and (S)-α-methylserotonin ((S)-αMS) (EC50 = 54 nM; Emax = 103%).[1]
See also
editReferences
editExternal links
edit